登录 | 注册    关注公众号  
微信公众号
搜索
 > 【BTLA】

BTLA信息

英文名称:B- and T-lymphocyte attenuator
中文名称:B和T淋巴细胞衰减因子
靶点别称:BTLA,B- and T-lymphocyte attenuator,B- and T-lymphocyte-associated protein,B And T Lymphocyte Associated,CD272 Antigen,BTLA1,CD272
上市药物数量:0
临床药物数量:5
最高研发阶段:临床三期

BTLA分子别名

BTLA,CD272

BTLA分子背景

B- and T-lymphocyte attenuator (BTLA) is also known as B- and T-lymphocyte-associated protein, CD antigen CD272. BTLA contains one Ig-like V-type (immunoglobulin-like) domain. As a lymphocyte inhibitory receptor, BTLA / CD272 inhibits lymphocytes during immune response. BTLA / CD272 can interact with tyrosine phosphatases PTPN6/SHP-1 and PTPN11/SHP-2, and interact with TNFRSF14/HVEM.

BTLA临床药物信息

英文名称 研发代码 研发阶段 公司 适应症 临床试验

消息提示

请输入您的联系方式,再点击提交!

确定